Oryzon continues to advance prosecution of its LSD1 patent portfolio worldwide
Oryzon announced today that it has recently received a notice of allowance from the European Patent Office (EPO) for one of its LSD1 composition-of-matter EP patent applications. This is Oryzon’s first LSD1 case to be accepted for grant at the EPO.